MedDataX Logo

Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

NCT ID: NCT01857635

Last Updated: 2015-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-02-28

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients suffering from hypercapnic respiratory failure and treated by non invasive ventilation (NIV), the interest of using transcutaneous CO2 measurement to evaluate PaCO2 and PaCO2 variation over time is unknown and will be evaluated in this study. Measurements will be done during one-hour NIV treatments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure

NCT01489150

Hypercapnic Respiratory Failure
COMPLETED

ReAcT CO2: A Study to Assess TcCO2 to Guide Acute NIV

NCT05674760

Acute Hypercapnic Respiratory Failure
UNKNOWN NA

Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients

NCT02260583

Chronic Obstructive Pulmonary Disease Patients Chronic Respiratory Failure
UNKNOWN NA

Transcutaneous CO2 Measurement - From Hospital to Home

NCT06694870

Type 2 Respiratory Failure Hypercapnic Respiratory Failure
COMPLETED

Noninvasive Ventilation After Extubation in Hypercapnic Patients

NCT01047852

Respiratory Failure
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercapnic Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ICU patient equipped with an arterial line
* NIV treatment prescribed by the clinician in charge
* Hypercapnia defined by PaCO2\> 42mmHg

Exclusion Criteria

* Severe hemodynamic instability
* Severe psychiatric disorders
* Denied consent
* Age \< 18 years
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lausanne Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Philippe Jolliet

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Jolliet, Prof

Role: PRINCIPAL_INVESTIGATOR

University of Lausanne Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Intensive care and burn unit, University hospital of Lausanne

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TpCO2-NIV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Negative Pressure Ventilation in Patients Hospitalized with Acute Hypercapnic Respiratory Failure
NCT06108284 RECRUITING NA
Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics
NCT02363920 COMPLETED PHASE4
Comparison of Transcutaneous Vs End-tidal CO2 Pressure Measurements in Hyperventilation Syndrome Diagnosis
NCT03614806 COMPLETED NA
Physiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure
NCT05675345 RECRUITING NA
Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation
NCT01513655 UNKNOWN PHASE4
NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP
NCT06047405 RECRUITING NA
Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure
NCT03443479 COMPLETED
Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective Study
NCT03572712 COMPLETED
Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring for the Prediction of Extubation Failure in the ICU
NCT02894177 COMPLETED NA
Clinical Trial Assessing Two Protocols to Withdraw Non-invasive Ventilation in Hypercapnic Respiratory Failure
NCT00775710 COMPLETED PHASE4
Clinical Stabilization of Hypercapnia: NIPPV v HVNI
NCT04709562 COMPLETED NA
Cardiac and Respiratory Function With Non-invasive Ventilation
NCT02699112 COMPLETED
Deventilation Dyspnea in COPD Patients Using NIV
NCT03503123 COMPLETED
High Flow Oxygen and Non Invasive Ventilation for Hypercapnic Respiratory Failure
NCT03627598 UNKNOWN NA
Weaning Form Mechanical Ventilation Using Extracorporeal CO2 Removal
NCT02259335 UNKNOWN NA
Extracorporeal CO2 Removal in Hypercapnic Patients
NCT02564406 COMPLETED NA
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
NCT01927237 WITHDRAWN NA
Changes in Spontaneous Ventilation in Response to Changes in Extracorporeal Carbon Dioxide Removal
NCT01953484 UNKNOWN NA
Clinical Efficacy of a Cephalic Mask for Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure
NCT00213395 TERMINATED NA
Predicting Fluid Responsiveness Using Transiently Increased Intrathoracic Pressure in Mechanically Ventilated Patients
NCT03413657 COMPLETED NA
End-tidal Carbon Dioxide Monitoring in Low Tidal Volume Ventilation
NCT04281589 COMPLETED NA
High Flow Oxygen VERSUS Non Invasive Ventilation Associated to Automated Flow Oxygen Titration After Patient Extubation
NCT03632577 COMPLETED NA
Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation
NCT01774422 UNKNOWN PHASE2
Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis
NCT06114667 NOT_YET_RECRUITING NA
Impact of High-level Oxygen Therapy on the Reconditioning of Type I Hypoxemic Respiratory Insufficiency Patients in Intensive Care
NCT04022603 COMPLETED NA